Orchestra BioMed Holdings Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
20.33
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-09-30
|
-0.39
|
-0.38
|
0.01
|
2.56%
|
|
2023-06-30
|
-0.41
|
-0.35
|
0.06
|
14.63%
|
|
2023-03-31
|
-0.28
|
-0.40
|
-0.12
|
-42.86%
|
|
2022-12-31
|
-1.71
|
-0.08
|
1.63
|
95.32%
|
|
2022-09-30
|
0.00
|
-0.05
|
-0.05
|
0.00%
|
|
2022-06-30
|
0.00
|
-0.04
|
-0.04
|
0.00%
|
|
2022-03-31
|
0.00
|
-0.02
|
-0.02
|
0.00%
|
|
2021-12-31
|
0.00
|
0.00
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2023-09-30
|
-1.13
|
|
2022-12-31
|
-0.19
|
|
2021-12-31
|
-0.02
|
|
2020-12-31
|
-0.01
|